appBliss GVS Pharma Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Not a good time to invest, stock is in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Bliss GVS Pharma Ltd
BLISSGVS
Price Chart
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Not a good time to invest, stock is in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Abbott India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
MRO-TEK Realty Ltd leads gainers in ‘B’ group
5 days ago•Business Standard
Bliss GVS Pharma reports consolidated net profit of Rs 27.94 crore in the December 2022 quarter
5 days ago•Business Standard
Recent EventsAll events
Copy of Newspaper Publication
Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download
Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download
Cash Dividend
Final • Div/Share: ₹ 0.5
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value